We serve Chemical Name:1-(4-Methylphenyl)-1-cyclohexanecarboxylic acid CAS:84682-27-9 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.
Chemical Name:1-(4-Methylphenyl)-1-cyclohexanecarboxylic acid
CAS.NO:84682-27-9
Synonyms:1-(4-methylphenyl)cyclohexane-1-carboxylic acid
Molecular Formula:C14H18O2
Molecular Weight:218.29200
HS Code:2916399090
Physical and Chemical Properties:
Melting point:166-170ºC
Boiling point:370.7ºC at 760 mmHg
Density:1.104 g/cm3
Index of Refraction:
PSA:37.30000
Exact Mass:218.13100
LogP:3.28150
Material Safety Information (Applicable for Hazard Chemicals)
RIDADR:
Packing Group:
Contact us for information like 1-(4-methylphenyl)cyclohexane-1-carboxylic acid chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,1-(4-methylphenyl)cyclohexane-1-carboxylic acid physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,1-(4-methylphenyl)cyclohexane-1-carboxylic acid Use and application,1-(4-methylphenyl)cyclohexane-1-carboxylic acid technical grade,usp/ep/jp grade.
Related News: Fate Therapeutics has exclusively licensed from MSK foundational intellectual property covering the production and composition of iPSC-derived T cells. 1-(4-Methylphenyl)-1-cyclohexanecarboxylic acid manufacturer A GSK spokesman said it was not yet clear by when ViiV would be able to address the FDA��s concerns. 1-(4-Methylphenyl)-1-cyclohexanecarboxylic acid supplier Beta Bionics is a for-profit Massachusetts public benefit corporation founded in 2015 to commercialize the iLet, a revolutionary bionic pancreas that is driven by mathematical dosing algorithms, which incorporate lifelong autonomous learning to automatically control glycemia. 1-(4-Methylphenyl)-1-cyclohexanecarboxylic acid vendor Fate Therapeutics has exclusively licensed from MSK foundational intellectual property covering the production and composition of iPSC-derived T cells. 1-(4-Methylphenyl)-1-cyclohexanecarboxylic acid factory The purpose of APIs according to the FDA is to cause ��pharmacological activity or other direct effects in the diagnosis, cure, mitigation, treatment or prevention of disease or to affect the structure and function of the human body.
